Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Pharmacovigilance Market Through 2034?
In recent times, there has been a notable rapid expansion in the pharmacovigilance market. Forecasts suggest an increase from $8.58 billion in 2024 to $9.64 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.4%. The significant growth witnessed during the historic period owes to factors such as the rising cases of adverse drug reactions (ADRs), escalation in research and development initiatives, an upsurge in drug development rates, increased attention towards personalized medicine, and a growing occurrence of chronic diseases.
The market for pharmacovigilance is predicted to grow swiftly in the coming years with a projected valuation of $15.5 billion in 2029, corresponding to a compound annual growth rate (CAGR) of 12.6%. The projected growth during the forecast timeframe can be ascribed to factors such as rising healthcare costs, enhanced government backing, and an aging population. Key trends for the forecast period comprise rising investments, the application of artificial intelligence, the integration of innovative platforms and cutting-edge cloud-based systems, along with strategic mergers and acquisitions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp
What Are the Core Growth Drivers Propelling the Pharmacovigilance Market Forward?
The pharmacovigilance market is being propelled forward by an increase in research and development initiatives. The creation of innovative and improved safety-profile drugs can be accomplished through investment in R&D by pharmaceutical firms. During the drug development procedure, rigorous preclinical and clinical tests enable early recognition of potential safety hazards, which paves the way for effective risk management strategies. Furthermore, advancements in technologies for monitoring adverse events, data analysis, and signal detection are facilitated by R&D activities, leading to earlier recognition of adverse drug reactions in the post-marketing stage. For example, in February 2024, the Llywodraeth Cymru Welsh Government, a government institution based in the UK, stated that in 2022, Wales devoted £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD), making up 1.9% of the UK’s total spending in this field. As a result, the pharmacovigilance market was bolstered by expanding research and development initiatives.
What Segment Types Define the Pharmacovigilance Market Structure?
The pharmacovigilance market covered in this report is segmented –
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Pharmacovigilance Market?
North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing thePharmacovigilance Industry Evolution?
Pharmacovigilance market players are leveraging artificial intelligence (AI) to enhance their operational efficiency. The use of AI in pharmacovigilance boosts the accuracy and effectiveness of activities associated with pharmacovigilance, leading to improved patient results. Employing AI allows pharmaceutical firms to facilitate their procedures, enhance the handling of data, and expedite the drug discovery process. It also aids in decreasing expenses and uplifting safety measures. For example, the Indian Government in August 2024, unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, initiated by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This specialized pharmacovigilance software aids in collecting and scrutinizing adverse events related to drugs and medical equipment, thereby simplifying the reporting process for consumers and healthcare professionals alike. This move significantly upgrades India’s pharmacovigilance framework by enabling a comprehensive acquisition of safety data and boosting the monitoring of drug safety. The core objective of the ADRMS is to augment the effectiveness of drug safety surveillance and adherence to standards, thereby solidifying India’s position as a frontrunner in the worldwide pharmaceutical sector.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
What Is the Definition of the Pharmacovigilance Market?
Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model